Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Richard Anthony Baylis, M.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Gole S, Tkachenko S, Masannat T, Baylis RA, Cherepanova OA. Endothelial-to-Mesenchymal Transition in Atherosclerosis: Friend or Foe? Cells. 2022 09 21; 11(19). PMID: 36230908; PMCID: PMC9563961.
    Citations:    Fields:    Translation:AnimalsCells
  2. Shin J, Tkachenko S, Chaklader M, Pletz C, Singh K, Bulut GB, Han YM, Mitchell K, Baylis RA, Kuzmin AA, Hu B, Lathia JD, Stenina-Adognravi O, Podrez E, Byzova TV, Owens GK, Cherepanova OA. Endothelial OCT4 is atheroprotective by preventing metabolic and phenotypic dysfunction. Cardiovasc Res. 2022 08 24; 118(11):2458-2477. PMID: 35325071.
    Citations:    Fields:    
  3. Gao H, Baylis RA, Luo L, Kojima Y, Bell CF, Ross EG, Wang F, Leeper NJ. Clustering cancers by shared transcriptional risk reveals novel targets for cancer therapy. Mol Cancer. 2022 05 18; 21(1):116. PMID: 35585548; PMCID: PMC9115915.
    Citations:    Fields:    Translation:Humans
  4. Jarr KU, Ye J, Kojima Y, Ye Z, Gao H, Schmid S, Luo L, Baylis RA, Lotfi M, Lopez N, Eberhard AV, Smith BR, Weissman IL, Maegdefessel L, Leeper NJ. The pleiotropic benefits of statins include the ability to reduce CD47 and amplify the effect of pro-efferocytic therapies in atherosclerosis. Nat Cardiovasc Res. 2022 Mar; 1(3):253-262. PMID: 35990913; PMCID: PMC9390974.
  5. Baylis RA, Smith NL, Klarin D, Fukaya E. Epidemiology and Genetics of Venous Thromboembolism and Chronic Venous Disease. Circ Res. 2021 06 11; 128(12):1988-2002. PMID: 34110897; PMCID: PMC8487638.
    Citations: 4     Fields:    Translation:Humans
  6. Newman AAC, Serbulea V, Baylis RA, Shankman LS, Bradley X, Alencar GF, Owsiany K, Deaton RA, Karnewar S, Shamsuzzaman S, Salamon A, Reddy MS, Guo L, Finn A, Virmani R, Cherepanova OA, Owens GK. Multiple cell types contribute to the atherosclerotic lesion fibrous cap by PDGFRß and bioenergetic mechanisms. Nat Metab. 2021 02; 3(2):166-181. PMID: 33619382; PMCID: PMC7905710.
    Citations: 16     Fields:    Translation:HumansAnimalsCells
  7. Alencar GF, Owsiany KM, Karnewar S, Sukhavasi K, Mocci G, Nguyen AT, Williams CM, Shamsuzzaman S, Mokry M, Henderson CA, Haskins R, Baylis RA, Finn AV, McNamara CA, Zunder ER, Venkata V, Pasterkamp G, Björkegren J, Bekiranov S, Owens GK. Stem Cell Pluripotency Genes Klf4 and Oct4 Regulate Complex SMC Phenotypic Changes Critical in Late-Stage Atherosclerotic Lesion Pathogenesis. Circulation. 2020 11 24; 142(21):2045-2059. PMID: 32674599; PMCID: PMC7682794.
    Citations: 55     Fields:    Translation:HumansAnimalsCells
  8. Hess DL, Kelly-Goss MR, Cherepanova OA, Nguyen AT, Baylis RA, Tkachenko S, Annex BH, Peirce SM, Owens GK. Perivascular cell-specific knockout of the stem cell pluripotency gene Oct4 inhibits angiogenesis. Nat Commun. 2019 02 27; 10(1):967. PMID: 30814500; PMCID: PMC6393549.
    Citations: 14     Fields:    Translation:AnimalsCells
  9. Mahan S, Liu M, Baylis RA, Gomez D. Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice. J Vis Exp. 2019 02 20; (144). PMID: 30855565; PMCID: PMC6698906.
    Citations:    Fields:    Translation:AnimalsCells
  10. Newman AA, Baylis RA, Hess DL, Griffith SD, Shankman LS, Cherepanova OA, Owens GK. Irradiation abolishes smooth muscle investment into vascular lesions in specific vascular beds. JCI Insight. 2018 08 09; 3(15). PMID: 30089722.
    Citations: 8     Fields:    Translation:HumansAnimalsCells
  11. Gomez D, Baylis RA, Durgin BG, Newman AAC, Alencar GF, Mahan S, St Hilaire C, Müller W, Waisman A, Francis SE, Pinteaux E, Randolph GJ, Gram H, Owens GK. Interleukin-1ß has atheroprotective effects in advanced atherosclerotic lesions of mice. Nat Med. 2018 09; 24(9):1418-1429. PMID: 30038218; PMCID: PMC6130822.
    Citations: 82     Fields:    Translation:AnimalsCells
  12. Baylis RA, Gomez D, Mallat Z, Pasterkamp G, Owens GK. The CANTOS Trial: One Important Step for Clinical Cardiology but a Giant Leap for Vascular Biology. Arterioscler Thromb Vasc Biol. 2017 11; 37(11):e174-e177. PMID: 28970294.
    Citations: 25     Fields:    Translation:Humans
  13. Baylis RA, Gomez D, Owens GK. Shifting the Focus of Preclinical, Murine Atherosclerosis Studies From Prevention to Late-Stage Intervention. Circ Res. 2017 03 03; 120(5):775-777. PMID: 28254801; PMCID: PMC5338643.
    Citations: 8     Fields:    Translation:HumansAnimals
  14. Andersson C, Kvist PH, McElhinney K, Baylis R, Gram LK, Pelzer H, Lauritzen B, Holm TL, Hogan S, Wu D, Turpin B, Miller W, Palumbo JS. Factor XIII Transglutaminase Supports the Resolution of Mucosal Damage in Experimental Colitis. PLoS One. 2015; 10(6):e0128113. PMID: 26098308.
    Citations: 4     Fields:    Translation:Animals
  15. Peske JD, Thompson ED, Gemta L, Baylis RA, Fu YX, Engelhard VH. Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity. Nat Commun. 2015 May 13; 6:7114. PMID: 25968334; PMCID: PMC4435831.
    Citations: 73     Fields:    Translation:AnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Baylis's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (96)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.